Withings’ newest hybrid smartwatch, the ScanWatch Horizon, merges a digital display with a traditional mechanical appearance. By acquiring a Withings device, you eliminate the now typical appearance of fitness wearables like Fitbit or Mi Bands. Plus, the onslaught of notifications provided by smartwatches isn’t an issue for those who actually prefer to keep things lowkey.
According to Withings, the 43mm ScanWatch Horizon has an anti-reflective sapphire-glass case, a rotating bezel made of stainless steel, and bright watch hands, making it visible in low light. Because the device only has 10 ATM of water resistance, deep dives are not practical. Swimming, surfing, snorkelling, and other aquatic sports should all be possible above 100m. Dive watches from Omega and Rolex can withstand depths of 300 metres (980 feet).
Although the ScanWatch Horizon has a heavy influence from diving watches, it can track over 30 different activities such as cycling, running, walking and swimming.
Using your phone’s GPS or Bluetooth-enabled device, you can keep tabs on your whereabouts. The battery also lasts up to 30 days before needing to be recharged. Your data is synchronised to your phone’s Withings Health Mate (iOS and Android) app, allowing you to track your progress and connect it to Google Fit, Strava, and other apps.
The watch’s sensors monitor heart rate and blood oxygen levels to determine your VO2 Max fitness level. When it detects an abnormal heart rhythm, it may prompt the user to take a 30-second ECG that’s apparently medical-level. The ScanWatch Horizon also monitors your sleep. The Horizon, like the first ScanWatch, can identify and notify users of potential issues that could indicate sleep apnea.
As FDA approval is currently in progress, the ECG claims, in particular, are prohibiting the ScanWatch and ScanWatch Horizon from going on sale in America. Due to “extraordinary circumstances”, the original clearance date of 2020 has since been delayed.
According to the business, the FDA is in regular contact with Withings, and clearance should be “within weeks2”. It has already acquired regulatory approval in several countries, including Europe, Australia, and the UK, to mention a few.
Doctors don’t rely on smartwatches alone to diagnose sleep apnea, and you shouldn’t either. While blood oxygen levels are an important metric for COVID– patients to monitor, wrist-worn sensors lack the precision of finger-mounted pulse oximeters.
The ScanWatch Horizon is currently available for less than $500 in the UK, France, and Germany. After getting FDA approval, it will be available in the States. Which, according to Withings, will be by the end of this year. Though you’ll have to move fast, it sold out within the first few days of launch.
If you’re interested in Withings, why not check out our review of the Withings Move?
Follow us on social media to stay up to date with our latest articles
Last Updated on December 31, 2021
Maygen is a multifaceted writer, proofreader, and experienced smartwatch industry writing and editing professional.
We appreciate her work, contribution to our blog, marketing skills, editing, and expert writing abilities which are second to none.
Truly adept in content strategy and content creation which has immense contribution to our blog.